Virax Biolabs Group Ltd (VRAX): Net earnings per share (EPS TTM)

Public company logo of Virax Biolabs Group Ltd (VRAX)

Virax Biolabs Group (VRAX) is recruiting leading immunologists to develop IT systems for viral profiling, enabling the expansion of a global network for diagnostics and digital health passports. Net earnings per share over the last four quarters illustrate this progress, with the -16.85 metric serving as the target level. Growth potential remains strong due to the deployment of mobile diagnostic platforms within the undersaturated market for rare pathologies.

VRAX viraxbiolabs.com Net earnings per share for the last four quarters (04/28/2023 - 11/17/2026)

Metric breakdowns and analytics for Virax Biolabs Corp (VRAX)

- current quotes and average value forecast:
General company analysis:viraxbiolabs.com (VRAX)
Manufactured products of Virax Biolabs Group Ltd

Fundamental asset screening requires precise measurement of capital efficiency. This indicator calculates the specific share of net income per share annually, neutralizing the impact of issuance. By analyzing the rolling annual earnings per share of Virax Biolabs Group (VRAX), an investor can discern the real business yield without market noise. The stability of this metric confirms the sustainable position of Virax Biolabs Group (VRAX) as a trusted supplier of diagnostic systems. A high level of market recognition ensures predictable profit generation.

Competitors of Virax Biolabs Group (VRAX)

agilent.com - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Quest Diagnostics Inc. DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months revvity.com|Earnings per share for the last twelve months BIO|Net earnings per share (EPS TTM) NNNN|SHC - Net earnings per one share for the last twelve months|Quidel Corporation - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) OPKO Health Corp. OPK|CDNA - Earnings per share for the last twelve months|Earnings per share for the trailing year MRVI (Maravai LifeSciences)|FLGT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months LAB|Earnings per share for the last twelve months Cytek Biosciences Inc|Net earnings per share (EPS TTM) OraSure Corp|Net earnings per share for the last 12 months XGN (Exagen Inc)|Net earnings per share (EPS TTM) mdxhealth.com (MDXH)|Net earnings per share (EPS TTM) LUCD (Lucid Diagnostics Inc)|PRE - Net earnings per share for the last 12 months|IMDX: Net earnings per share for the last 12 months|Earnings per share for the trailing year TRIB (trinitybiotech.com)|PRPH (ProPhase Labs, Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Ainos|Earnings per share for the last twelve months Co-Diagnostics Inc|HSCS (Heart Test Laboratories Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) BMRA|Cardio Diagnostics Holdings Inc. (CDIO) - Net earnings per share for the trailing year|Earnings per share for the last twelve months Onconetix ONCO|Net earnings per share for the trailing year bluejaydx.com|AWH: Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Accelerate Diagnostics, Inc. AXDX|CNTG (CENTOGENE) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months ENZ|FRES: Net earnings per share for the last four quarters|Earnings per share for the last twelve months GENE|Net earnings per share for the last 12 months ME (23andMe Holding Co)|PMD - Net earnings per one share for the last twelve months